[en] Aging-related biomolecular changes in the human brain are thought to be associated with an increased risk for neurodegenerative diseases. In particular, aging and Parkinson’s disease (PD) share various molecular hallmarks, including a gradual decline in dopamine synthesis and increased levels of deleted mitochondrial DNA. While some specific mechanistic links between brain aging and PD have been proposed and investigated previously, systematic analyses of shared molecular alterations at a genome-scale level are required to obtain a better understanding of the affected cellular processes and their interrelations.
We present a joint analysis of high-throughput brain transcriptomics data from PD patients and unaffected individuals from different adult age groups using a statistical meta-analysis and a recently published pathway and network analysis approach.
Our analyses provide statistical evidence for specific functional associations between molecular network changes in PD and aging, identify new significant joint pathway deregulations and suggest mechanistic explanations for the observed age-dependence of PD risk.
Centre de recherche :
Luxembourg Centre for Systems Biomedicine (LCSB)
Disciplines :
Biotechnologie Neurologie
Auteur, co-auteur :
GLAAB, Enrico ; University of Luxembourg > Luxembourg Centre for Systems Biomedicine (LCSB)
SCHNEIDER, Reinhard ; University of Luxembourg > Luxembourg Centre for Systems Biomedicine (LCSB)
Co-auteurs externes :
no
Langue du document :
Anglais
Titre :
Shared alterations in the human brain transcriptome during adult aging and in Parkinson's disease
Date de publication/diffusion :
15 juin 2015
Nom de la manifestation :
EMBO Symposium on Mechanisms of Neurodegeneration 2015
Organisateur de la manifestation :
European Molecular Biology Organization, European Molecular Biology Laboratory
Lieu de la manifestation :
Heidelberg, Allemagne
Date de la manifestation :
from 14-06-2015 to 17-06-2015
Manifestation à portée :
International
Projet FnR :
FNR5782168 - Exploring Parkinson'S Disease Inhibitor Efficacy On A Non-dopaminergic Target, 2013 (01/12/2013-31/05/2016) - Enrico Glaab